Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Liver Diseases

Free Subscription 19.01.2026 1 Biochem Biophys Res Commun 1 BMC Cancer 6 BMC Gastroenterol 1 Dig Dis Sci 1 Endoscopy 1 Gut 9 Hepatology 2 J Gastroenterol Hepatol 2 J Hepatol 1 PLoS Med 3 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biochem Biophys Res Commun

1. FANG X, Liang Z, Zhang Z, Tao M, et al
   Natural exosome-like nanovesicles from Smilax China rhizome induce mitophagy-dependent ferroptosis in hepatocellular carcinoma via GPX4/ACSL4 axis.
   Biochem Biophys Res Commun. 2026;800:153270.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. GUASTELLA R, Perri G, Bassi D, Canitano N, et al
   Conversion surgery vs. standard of care in pancreaTic cancer oligometastatic to the liver (SONAR: Surgery in Oligometastatic paNcreatic cAnceR) a randomized controlled trial.
   BMC Cancer. 2026;26:44.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

3. ZOU J, Tian F, Cui S, Hou J, et al
   Comparative efficacy of different diet modalities on metabolic profiles and liver functions in metabolic dysfunction-associated fatty liver disease: a network meta-analysis.
   BMC Gastroenterol. 2025;26:25.
   PubMed         Abstract available
   
   
4. LI Y, Jiang C, Wang Z, Liu L, et al
   Application of laparoscopic liver surgery techniques in laparoscopic thermal ablation of liver tumors.
   BMC Gastroenterol. 2025;26:19.
   PubMed         Abstract available
   
   
5. ZHONG Z, Xu M, Luo X, Tan J, et al
   Global, regional, and national burden of NAFLD in adults aged 20-49 years (1990-2021): a comprehensive analysis of trends, decomposition, and health inequality.
   BMC Gastroenterol. 2025;26:23.
   PubMed         Abstract available
   
   
6. KHACHIDZE T, Sulaberidze G, Barbakadze G
   Prevalence and risk factors of metabolic dysfunction-associated fatty liver disease in the adult Georgian population: a nationwide multiregional clinic-based study.
   BMC Gastroenterol. 2025;26:17.
   PubMed         Abstract available
   
   
7. OZONO Y, Kawakami H, Hatada H, Uchiyama N, et al
   Tofogliflozin attenuates liver steatosis and fibrosis in non-diabetic non-alcoholic steatohepatitis mice.
   BMC Gastroenterol. 2026 Jan 15. doi: 10.1186/s12876-026-04610.
   PubMed         Abstract available
   
   
8. CAI F, Yu J, Qin L
   Impact of preoperative triglyceride levels on hepatic encephalopathy development in TIPS patients: a retrospective cohort study.
   BMC Gastroenterol. 2026 Jan 12. doi: 10.1186/s12876-025-04583.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

9. WILLIAMS EE, Lammert C, Vuppalanchi R
   Impact of Type 2 Diabetes Mellitus on Liver Fibrosis and Hepatic Steatosis in Patients with Primary Biliary Cholangitis: A Longitudinal Study.
   Dig Dis Sci. 2026 Jan 12. doi: 10.1007/s10620-026-09672.
   PubMed         Abstract available
   
   

   
   Endoscopy

10. SOGA K, Yamaguchi M, Kuwada M, Shirahashi R, et al
    A rare case of hepatic hilar lymphangioma diagnosed using endoscopic and transabdominal ultrasonography.
    Endoscopy. 2026;58.
    PubMed        
    
    

    
    Gut

11. DUTTA RK, Du K, Ren N, Umbaugh DS, et al
    Zinc-dependent RNA-binding protein controls hepatocyte senescence and recovery from alcohol-related liver failure.
    Gut. 2026 Jan 13:gutjnl-2025-337019. doi: 10.1136/gutjnl-2025-337019.
    PubMed         Abstract available
    
    

    
    Hepatology

12. WANG W, Yin S, Xu Q, Song D, et al
    Biologically interpretable deep learning-derived MRI phenotypes reveal lymph node involvement and neoadjuvant therapy response in intrahepatic cholangiocarcinoma.
    Hepatology. 2026 Jan 12. doi: 10.1097/HEP.0000000000001671.
    PubMed         Abstract available
    
    
13. ZHANG VX, Suoangbaji T, Tsui YM, Sze KM, et al
    Repurposing resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression.
    Hepatology. 2026 Jan 12. doi: 10.1097/HEP.0000000000001675.
    PubMed         Abstract available
    
    
14. ALLAIRE M, Bargellini I
    Hepatocellular carcinoma with macrovascular invasion : Navigating heterogeneous evidence.
    Hepatology. 2026 Jan 14. doi: 10.1097/HEP.0000000000001679.
    PubMed        
    
    
15. WANG JJ, Lee YT, Kim AK, Villauneva A, et al
    Clinical utilization of testing for cell-free DNA in hepatocellular cancer.
    Hepatology. 2026 Jan 14. doi: 10.1097/HEP.0000000000001676.
    PubMed         Abstract available
    
    
16. ERICKSON H
    Fueling fibrosis: The PBX1-IL7R axis and its role in hepatic stellate cell activation.
    Hepatology. 2026;83:197-198.
    PubMed        
    
    
17. DING W, Wu J, Dou J, Liu F, et al
    Biologically explicable multimodal model predicting local tumor progression and tumor invasiveness of hepatocellular carcinoma.
    Hepatology. 2026 Jan 15. doi: 10.1097/HEP.0000000000001678.
    PubMed         Abstract available
    
    
18. YAMAMOTO S, Kodama T, Kuwano A, Maesaka K, et al
    NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma.
    Hepatology. 2026 Jan 15. doi: 10.1097/HEP.0000000000001677.
    PubMed         Abstract available
    
    
19. ALLEN AM, Kim WR, Carrieri P, Canning R, et al
    Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease.
    Hepatology. 2026;83:362-373.
    PubMed         Abstract available
    
    
20. LAI JC, Shui AM, Molinari M, Rahimi R, et al
    The Liver Transplant Comorbidity Index (LTCI) : A composite index of ambulatory Pre-LT factors to identify patients at increased risk of Post-LT Mortality.
    Hepatology. 2025 Mar 25. doi: 10.1097/HEP.0000000000001320.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

21. KO KA, Sohn W
    Response to the Letter on "Role of ALBI Grade as a Predictive Factor for Long-Term Mortality in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)".
    J Gastroenterol Hepatol. 2026 Jan 15. doi: 10.1111/jgh.70246.
    PubMed        
    
    
22. INOUE T, Kitano R, Kitada T, Sakamoto K, et al
    Endoscopic Ultrasound-Guided Bilateral Stent-in-Stent Deployment With Hepaticoenterostomy in patients With Malignant Hilar Biliary Obstruction.
    J Gastroenterol Hepatol. 2026 Jan 15. doi: 10.1111/jgh.70236.
    PubMed         Abstract available
    
    

    
    J Hepatol

23. LUUKKONEN PK
    Redox-dependent substrate use in hepatic gluconeogenesis shapes exercise performance.
    J Hepatol. 2026 Jan 13:S0168-8278(25)02726-6. doi: 10.1016/j.jhep.2025.
    PubMed        
    
    
24. LUO X, Xiang Z, Yang Z
    Emergency granulopoiesis in decompensated cirrhosis: mechanistic and therapeutic considerations.
    J Hepatol. 2026 Jan 9:S0168-8278(26)00005-X. doi: 10.1016/j.jhep.2025.
    PubMed        
    
    

    
    PLoS Med

25. YANG K, Lee J, Jang JW, Sung PS, et al
    Evaluating the clinical utility of large language models for hepatocellular carcinoma treatment recommendations: A nationwide retrospective registry study.
    PLoS Med. 2026;23:e1004855.
    PubMed         Abstract available
    
    

    
    Radiology

26. GEORGIADES C
    Intrahepatic Cholangiocarcinoma: Local-Regional Therapies Join the Fight.
    Radiology. 2026;318:e253806.
    PubMed        
    
    
27. CHEN S, Qi H, Shen L, Lin L, et al
    Noninvasive Profiling for PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
    Radiology. 2026;318:e252521.
    PubMed        
    
    
28. PANG C, Li J, An C, Wang Z, et al
    Survival Outcomes of Microwave Ablation Compared with Repeat Liver Resection in the Treatment of Recurrent Intrahepatic Cholangiocarcinoma.
    Radiology. 2026;318:e243254.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum